Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Access content directly
Conference Poster Year : 2022

Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis

Domains

Immunology
Bayer Alexandra Myology 2022 Nice.pdf (68.92 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Jean-Thomas Vilquin  : Connect in order to contact the contributor

https://hal.science/hal-03824304

Submitted on : Friday, October 21, 2022-2:31:47 PM

Last modification on : Saturday, October 7, 2023-9:36:25 PM

Download

Dates and versions

hal-03824304 , version 1 (21-10-2022)

Identifiers

  • HAL Id : hal-03824304 , version 1

Cite

Alexandra Bayer Wildberger, Cinthia Bergman, Natalia Pinzon, Axel You, Frédérique Truffault, et al.. Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis. 7th International Myology Congress, Sep 2022, Nice, France. ⟨hal-03824304⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

U974 SORBONNE-UNIVERSITE SU-MEDECINE U974-E7
44 View
17 Download

Share

Gmail Facebook X LinkedIn More